# Evaluation of the Tympanostomy Tube Delivery System

> **NCT01202578** · PHASE2,PHASE3 · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 53 (actual)

## Conditions studied

- Otitis Media With Effusion
- Acute Otitis Media

## Interventions

- **DEVICE:** tympanostomy tube

## Key facts

- **NCT ID:** NCT01202578
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202578, "Evaluation of the Tympanostomy Tube Delivery System". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01202578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*